The QualityStocks Daily Friday, September 7th, 2018

Today's Top 3 StockMarketWatch


MegaPennyStocks (GDET) +32.08%

QualityStocks (THMG) +28.81%

The QualityStocks Daily Stock List

First Choice Healthcare Solutions, Inc. (FCHS)

007 Stock Chat, PennyStockSpy, Greenbackers, StocksImpossible, TheMicrocapNews, First Penny Picks, Marketbeat and OTCBB Journal reported on First Choice Healthcare Solutions, Inc. (FCHS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

First Choice Healthcare Solutions, Inc. (FCHS) engages in owning and operating multi-specialty (non-physician-owned) medical centers of excellence throughout the southeastern U.S. The Company is one of the nation's only non-physician-owned, publicly traded healthcare services enterprises centered on the delivery of total musculoskeletal solutions with a focus on Orthopaedic and Spine care. FCHS is based in Melbourne, Florida.

Currently, the Company’s flagship integrated platform administers greater than 100,000 patient visits annually. The platform consists of First Choice Medical Group, The B.A.C.K. Center, and Crane Creek Surgery Center. FCHS medical centers of excellence concentrate on treating patients in different specialties. This includes Orthopaedics, Spine Surgery, Neurology, Interventional Pain Management, and related diagnostic and ancillary services.

First Choice Medical Group (Melbourne, Florida) is the Company’s flagship multi-specialty medical center of excellence. First Choice Medical Group specializes in the delivery of musculoskeletal medicine and rehabilitative care with manifold quality-focused goals focused on enriching its patients’ care experience.

FCHS has expanded its portfolio of Medical Centers of Excellence in the Florida Space Coast area with its Brevard Orthopaedic Spine & Pain Clinic, Inc. (d/b/a The B.A.C.K. Center). The B.A.C.K. Center is a leading, advanced orthopaedic spine and pain practice in Brevard County, Florida.

FCHS’s Crane Creek Surgery Center is an AAAHC accredited facility. Its dedication is to deliver first-class, ambulatory surgical care in a convenient, comfortable outpatient environment. The 18,000-plus sq. ft. facility is in Melbourne, Florida within the Crane Creek Medical Center building. Moreover, this building is home to The B.A.C.K. Center.

Today, First Choice Healthcare Solutions announced the appointment of Mr. James Renna, Dr. Thomas Gill, and Mr. Gary Augusta to the Board of Directors, effective October 1, 2018.

Chris Romandetti, First Choice Healthcare Solutions’ President and Chief Executive Officer, said, "We are honored to have such accomplished representation on our Board of Directors by adding Mr. Renna, Dr. Gill and Mr. Augusta. Mr. Renna’s experience in corporate finance and governance, and Dr. Gill’s extensive medical experience and Mr. Augusta’s background in healthcare and strategic planning puts First Choice at the forefront of Orthopaedic and Spine care procedures and treatments.”

First Choice Healthcare Solutions, Inc. (FCHS), closed Friday's trading session at $1.13, even for the day, on 28,450 volume. The average volume for the last 60 days is 12,045 and the stock's 52-week low/high is $0.90/$1.46.


Barfresh Food Group, Inc. (BRFH)

RedChip, Lions of Wall Street, The Wall Street Transcript, SmallCap Network, Wall Street Resources, Greenbackers, OTCJournal, Barchart, Marketbeat, and SmallCapVoice reported on Barfresh Food Group, Inc. (BRFH), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Barfresh Food Group, Inc. is a manufacturer and distributor of innovative, frozen, ready-to-blend beverages. These include smoothies, shakes, and frappes. These products are chiefly for restaurant chains and the foodservice industry. Barfresh Food Group and Barfresh Food Group Pty Ltd. in Australia (Barfresh Australia) are under common control. OTCQB-listed, Barfresh Food Group has its corporate office in Beverly Hills, California.

Barfresh Food Group acquired the exclusive global patent rights to its ready-to-blend beverage packs. This is on top of its currently held patent rights in the U.S. and Canada.  It has acquired the intellectual property (IP) for its creative “ready to blend” ingredient packs for North America. The Company’s proprietary, patented system uses portion-controlled pre-packaged beverage ingredients. These deliver freshly made smoothies that are quick, cost efficient, and without waste.

The unique system combines all the ingredients of a quality smoothie into an individually pre-portioned pack. The pack contains real fruit pieces, low fat frozen yogurt or sorbet, fruit juice, and ice. This is then blended with water to create a smoothie.

Recently, Barfresh Food Group provided an update on recent business developments in association with the filing of its form 10-Q for Q2 ended June 30, 2018. US GAAP Revenue for Q2 2018 was $1,086,000. This represents an increase of 73 percent versus $629,000 in Q2 2017. Gross Margin for Q2 was 52.2 percent. This represents an improvement over 2017’s Q2 Gross Margin of 51.2 percent.

Operating Loss for Q2 2018 lessened to $1.8 million, versus $2.2 million in Q2 2017. As of June 30, 2018, Barfresh had $854,000 of cash and $1.4 million of inventory on its balance sheet.

Barfresh Food Group has approval to sell its products into all branches of the U.S. Armed Forces. This covers bases around the world that are home to 1.3 million active troops. Barfresh has entered into agreements expanding to 45 military locations.      

Barfresh Food Group, Inc. (BRFH), closed Friday's trading session at $0.4649, up 3.31%, on 9,800 volume. The average volume for the last 60 days is 54,543 and the stock's 52-week low/high is $0.35/$0.73.


Concierge Technologies, Inc. (CNCG)

OnPointStockAlert, Penny Stock Prodigy, Penny Stock Titans, ProTrader, The Street, TopPennyStockMovers, Epic Stock Picks, Nebula Stocks, MicrocapVoice, OTCPicks, PennyStocks24, Pumps and Dumps, EpicVIP Group, MomentumOTC, and Light Speed Stocks reported earlier on Concierge Technologies, Inc. (CNCG), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Concierge Technologies, Inc. operates by way of its wholly-owned subsidiary company Kahnalytics, Inc., and also operates via Brigadier Security Systems and Wainwright Holdings. In addition, the Company acquired Gourmet Foods. Ltd. of Tauranga, New Zealand. Concierge Technologies is based in Valley Center, California. The Company now operates on a global scale with wholly-owned subsidiaries in the United States, New Zealand, and Canada.

In June of 2015, Concierge Technologies founded Kahnalytics, Inc. Kahnalytics is a U.S. based provider of live streaming mobile video, vehicle tracking, and driver behavior data.

Furthermore, USCF is a subsidiary of Concierge Technologies. USCF operates on the vanguard of product innovation as an asset management firm offering exchange-traded products (ETPs), exchange-traded funds (ETFs), as well as mutual funds.

Gourmet Foods is a well-established producer of popular New Zealand meat pies and bakery products under recognized supermarket brand names “Pat’s Pantry” and “Ponsonby Pies”. Gourmet Foods products are in convenience stores, major supermarkets, petrol stations, and restaurants. Gourmet Foods distributes more than 30 products across New Zealand.

On June 2, 2016, Concierge Technologies acquired Brigadier Security Systems of Saskatoon, Saskatchewan. Brigadier is an alarm installation and monitoring company. It is a long-standing security alarm business serving the Province of Saskatchewan since 1985.

Brigadier has security solutions ranging from products designed to protect residential premises and property through to complex access control and camera monitoring equipment. Brigadier Security Systems operates under the trade name Elite Security.

In December 2017, Concierge Technologies announced that its wholly-owned California subsidiary Kahnalytics acquired all of the assets and business of Original Sprout LLC, a California Limited Liability Company (OS). As of December 19, 2017, Kahnalytics started operations under the fictitious business name "Original Sprout" from its location in San Clemente, California. The transition of the former Kahnalytics live-streaming business to the business of Original Sprout has now been completed.

Original Sprout is a manufacturer and distributor of clean, non-toxic, all-natural hair care and skin products. It was founded by master hair stylist Inga Tritt in 2003.

Concierge Technologies, Inc. (CNCG), closed Friday's trading session at $1.00, up 12.61%, on 210 volume. The average volume for the last 60 days is 901 and the stock's 52-week low/high is $0.55/$3.00.


Thunder Mountain Gold, Inc. (THMG)

Zacks, FeedBlitz, and MarketWatch reported on Thunder Mountain Gold, Inc. (THMG), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Thunder Mountain Gold, Inc. is a junior gold exploration company headquartered in Boise, Idaho. The Company owns interests in numerous United States precious metals projects. Its chief asset is The South Mountain Project. The South Mountain Project is on private and patented land in southern Idaho, just north of the Nevada border. Formed in 1935, Thunder Mountain Gold lists on the OTC Markets’ OTCQB.

Another important asset of the Company is the Trout Creek Project. The Trout Creek target is in the Reese River Valley area south of Battle Mountain, Lander County, Nevada.

This is a grass roots gold target in the Eureka-Battle Mountain trend of central Nevada, now under Joint Exploration Agreement with Newmont USA Limited. This target consists of 60 unpatented lode mining claims.

Trout Creek is on an important trend with Newmont's Phoenix Mine and the Gold Acres, Pipeline. The Cortez Mine sits to the southeast.

Thunder Mountain Gold signed an Amendment, which modifies and extends the exploration Minerals Lease and Agreement with Newmont USA Limited on the Trout Creek Project. The extension allows it more time to complete work requirements on the project and reduces the yearly work obligations.

Thunder Mountain Gold’s other projects include Clover Mountain. The Company controls 40 unpatented lode mining claims covering about 800 acres, near Clover Mountain in Owyhee County, Idaho. In addition, the Company’s West Tonopah Property consists of 8 unpatented lode mining claims totaling 160 acres in the Tonopah Mining District, Esmeralda County, Nevada.

Thunder Mountain Gold owns 100 percent of the aforementioned South Mountain Mine. This mine has a land package comprising approximately 1,200 acres of mostly private land - both owned outright and leased. In 2009, a new gold discovery was revealed during fieldwork at South Mountain. The Company’s plan of operation for this, subject to business conditions, is to continue to advance the development at the South Mountain Project.

In fact, the South Mountain Project remains Thunder Mountain Gold’s focus. The flagship South Mountain Project was initially mined in the late 1800s. The primary metals at South Mountain are silver, zinc, lead, copper, and gold.

The South Mountain Mine property was mined underground extensively during World War II. Smelter records for direct ship from the mine during the periods 1940 through 1954 showed a total of 53,642 tons of ore that contained 15,593,000 pounds of zinc (14.5 percent), 2,562,300 pounds of lead (2.4 percent), 1,485,200 pounds of copper (1.4 percent), 566,439 ounces of silver (10.6 ounces per ton)(opt) and 3,120 ounces of gold (0.058 opt).

Thunder Mountain Gold, Inc. (THMG), closed Friday's trading session at $0.1199, up 28.81%, on 10,000 volume. The average volume for the last 60 days is 11,270 and the stock's 52-week low/high is $0.08/$0.29.


Fiore Gold Ltd. (FIOGF)

Investors Hangout, Stockhouse, Stockwatch, Energy and Gold, Stock Orange, Barchart, and WatchDog Stocks reported on Fiore Gold Ltd. (FIOGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Fiore Gold Ltd. is a new America’s-focused gold producer and explorer. The Company has the producing Pan Mine in the State of Nevada. Additionally, it has a group of exploration projects in Nevada, Washington and Chile. Fiore Gold has offices in Toronto, Ontario; Vancouver, British Columbia; and Englewood, Colorado. The Company lists on the OTC Markets Group’s OTCQB.

Fiore Gold’s objective is to build a new mid-tier mining company in the world’s top mining jurisdictions. Its initial goal is on becoming a 150,000-ounce/year gold producer. Concerning South American Properties, the Company has its Pampas El Peñon properties; the Cerro Tostado project; and the Rio Loa property. The Pampas El Peñon property comprises 13 mining claims totaling 3,400 hectares. It is situated about 130 kilometers southeast of Antofagasta, Chile.

The Cerro Tostado (South America) project consists of five concessions totaling roughly 1,500 ha located in Region II about 125 km southeast of Antofagasta. The Rio Loa property is in the northern part of the prolific Maricunga gold belt. The 1,000 Ha Rio Loa property is approximately 25 km south of Salares Norte.

Regarding North American Projects, Fiore Gold’s assets include the above-mentioned producing Pan Mine near Eureka, Nevada. In addition, assets include the nearby Gold Rock exploration project. The Company also controls the Golden Eagle advanced exploration project in Washington State.

The Pan Mine is a Carlin-style, sediment-hosted, gold-only deposit. It comprises three main zones of mineralization, which has now been traced for over 6,000 feet along the north-south Branham Fault. The 2017 Pan Mine Feasibility Study (FS) defines Proven and Probable reserves of 318,000 gold ounces at an average grade of 0.51 g/t gold (0.015 oz/ton).

Fiore Gold previously announced the start of exploration drilling at its Pan Mine in Nevada, as part of a longer-term program intended to expand the resource and reserve base at Pan. The present program will consist of roughly 11,500 feet of reverse circulation drilling and be focused in the area of the North Pit that hosts most of the silica-rich rocky ore at Pan. Drilling will also take place in the Central area of the deposit to expand existing resources there and test new targets.

Fiore Gold Ltd. (FIOGF), closed Friday's trading session at $0.26, up 4.00%, on 23,987 volume. The average volume for the last 60 days is 46,406 and the stock's 52-week low/high is $0.35/$0.73.


AmeriCann, Inc. (ACAN)

Real Pennies, TopPennyStockMovers, Promotion Stock Secrets, Cannabis Financial Network News, OTC Markets Group, SmallCapVoice, and TheMicrocapNews reported on AmeriCann, Inc. (ACAN), and we also report on the Company, here at the QualityStocks Daily Newsletter.

AmeriCann, Inc. is developing sustainable, state-of-the-art medical cannabis cultivation properties. The Company is a national leader of sustainable cultivation and processing infrastructure for the medical marijuana industry. It designs, builds, and and owns efficient cultivation and processing facilities to produce medical cannabis. It is developing projects across the country in regulated markets through the “Preferred Partner Program”. An Agricultural Technology Company, AmeriCann has its corporate headquarters in Denver, Colorado.

AmeriCann is developing a 53-acre property in Massachusetts as the Massachusetts Medical Cannabis Center (the MMCC). The MMCC has approval for 1 million square feet. The expectation is that it will be one of the most technologically advanced cultivation facilities in the nation.

AmeriCann’s mission is to serve medical cannabis patients through providing facilities designed and constructed to produce high quality, consistent medicine, cultivated and processed in a controlled, secure, and sustainable environment. The Company identifies, acquires, and develops real estate particularly suited for cannabis operations. It finances real estate development. Moreover, it provides necessary venture capital to developing cannabis enterprises.

AmeriCann announced in September of 2017 that Coastal Compassion, Inc. (CCI), its Preferred Partner in Massachusetts, received a Final Certificate of Registration from the Department of Public Health. CCI is one of a limited number of vertically integrated companies approved to cultivate, process and ultimately dispense medical cannabis in the Massachusetts Medical-Use of Marijuana program.

With the Final Certificate of Registration, CCI has all the approvals to commence cultivation in its fully-constructed Registered Marijuana Dispensary (RMD) in Fairhaven, Massachusetts. The Fairhaven RMD will house CCI's first cultivation and processing operations and a permanent retail dispensary location.

AmeriCann has agreements with Coastal Compassion to lease 100 percent of the first phase of MMCC that will consist of a 30,000 square foot greenhouse, laboratory, as well as research center.

This past January, AmeriCann provided its analysis of Attorney General Jeffrey Sessions’ memo issued on January 5, 2018 concerning federal marijuana enforcement.

Mr. Tim Keogh, AmeriCann’s President and Chief Executive Officer, stated, "Cannabis has been regulated successfully at the state level since 1996. We expected the new leadership within the Department of Justice to implement their own policies. However, we don't anticipate that the change in policies at the DOJ will significantly impact patients, consumers or businesses that comply with state regulations."

AmeriCann, Inc. (ACAN), closed Friday's trading session at $2.37, up 3.04%, on 35,402 volume. The average volume for the last 60 days is 64,132 and the stock's 52-week low/high is $1.56/$5.35.


Alacer Gold Corp. (ALIAF)

Silverstocker, InvestorPlace, Gold Stock Data, Northern Miner, 4-Traders, Investopedia, OTC Markets, MarketWatch, TradingView, Investing, The Street, Mining Feeds, Information Vine, and Penny Stock Tweets reported on Alacer Gold Corp. (ALIAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Alacer Gold Corp. is a leading intermediate gold mining company whose shares trade on the OTC Markets. The Company has an 80 percent interest in the world-class Çöpler Gold Mine in Turkey operated by Anagold Madencilik Sanayi ve Ticaret A.S. The remaining 20 percent is owned by Lidya Madencilik Sanayi ve Ticaret A.S.  Alacer Gold is pursuing initiatives to enhance value beyond the current mine plan. Alacer Gold has its corporate headquarters in Denver, Colorado.

Alacer’s principal focus is to leverage its cornerstone Çöpler Mine and strong balance sheet to maximize portfolio value, maximize free cash flow, and minimize project risk. The Çöpler Mine is situated in east-central Turkey in the Erzincan Province.

Çöpler has substantial Probable Reserves of 4 million recoverable ounces and Measured and Indicated Resources of 6 million ounces of contained gold. These provide the basis for Çöpler’s 20-year mine life. Currently, the Mine is an open-pit, heap-leach operation producing low-cost gold from oxide ore. Over the life of the current heap-leach project, about 76 percent of the gold contained in the oxide ore is expected to be recovered.

Alacer Gold’s Board of Directors approved full construction of the Sulfide Project at the Çöpler Gold Mine in May 2016. The Çöpler orebody contains refractory sulfide ore. This requires a different processing solution than heap-leaching to extract the gold.

The expectation is that the Sulfide Project will deliver long-term growth with good financial returns and adds 20 years of production at the Çöpler Gold Mine. The Sulfide Project capital cost estimate has been decreased from $744 million to $673 million.

This week, Alacer Gold announced the processing of the first oxide ore through the crushing and grinding circuit over the past weekend. The rest of the plant, including the acidulation, pressure oxidation and counter current decantation circuits (the Sulfide Circuit), will start once the Sulfide Circuit commissioning

is complete and the oxide circuit is completely operational and stabilized.

In July, Alacer Gold announced additional positive drilling results at Ardich within the Çöpler District in a press release entitled “Alacer Gold Announces Additional Positive Drill Results for the Ardich Gold Prospect, including 50.2 Meters at 3.01 Grams per Tonne Gold Near Surface”

Alacer Gold Corp. (ALIAF), closed Friday's trading session at $1.7499, down 1.69%, on 1,993 volume. The average volume for the last 60 days is 27,881 and the stock's 52-week low/high is $1.53/$2.28.


Fortescue Metals Group Limited (FSUMF)

Investor Village, Equity Clock, OTC Markets, Current Charts, Wallet Investor, Marketbeat, InvestorsHub, YCharts, and TradingView reported on Fortescue Metals Group Limited (FSUMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Fortescue Metals Group Limited is a global leader in the iron ore industry. The Company has grown to be one of the largest global iron ore producers. It now produces 170 million tonnes of iron ore per annum. Fortescue Metals Group lists on the OTC Markets Group’s OTCQX. The Company has its head office in East Perth, Western Australia.

Fortescue Metals owns and operates integrated operations encompassing three mine sites in the Pilbara, the five berth Herb Elliott Port in Port Hedland, and the fastest, heavy haul railway in the world. Fortescue presently supplies 17 per cent of China’s seaborne iron ore. The Company has a fleet of four Fortescue Ore Carriers. Four more are to be delivered in Fiscal Year (FY) 2018.

Fortescue Mining is the first company in Western Australia to control a railway from outside an area of operation. In addition, it is the first company worldwide to use CAT autonomous haulage technology on a commercial scale. Fortescue continues to undertake early stage, low cost exploration on coppergold prospective tenements in South Australia and New South Wales. Furthermore, it has assessed high potential, early stage exploration tenements in Ecuador, where it was granted 32 exploration areas.

The Company has expanded autonomous haulage at Chichester Hub. The expansion of its autonomous haul fleet has marked a significant milestone, with the first trucks fitted with Autonomous Haulage Technology (AHS) currently in operation at Christmas Creek.

The conversion of about 100 haul trucks at the Chichester Hub will see Fortescue Metals Group become the first iron ore operation globally to have a fully autonomous fleet. The Chichester Hub in the Chichester Ranges, comprising the Cloudbreak and Christmas Creek mines, has a yearly production capacity of 100mtpa from three Ore Processing Facilities (OPF).

Fortescue Metals has its Iron Ore Projects. Its Iron Bridge Project is 100 kilometers south of Port Hedland. This is a JV between Fortescue Metals Group, Taiwan’s Formosa Group, and China’s Baosteel Group, incorporating the world class North Star and Glacier Valley Magnetite ore bodies. Its Iron Ore Projects also include the Firetail Replacement Project. Firetail is an important element of the Fortescue Blend product.

Also, Fortescue’s operations include The Solomon Hub in the Hamersley Ranges. The Solomon Hub is situated 60 kilometers north of Tom Price and 120 kilometers to the west of Fortescue Metals’ Chichester Hub.

The Company wholly owns and operates its purpose designed rail and port facilities. These were built to deliver iron ore from its mines to Port Hedland and on to its customers. The Company’s railway covers 620 kilometers of track.

Fortescue Metals Group Limited (FSUMF), closed Friday's trading session at $2.62, up 0.38%, on 385 volume. The average volume for the last 60 days is 15,195 and the stock's 52-week low/high is $2.53/$4.75.


NeuroOne Medical Technologies Corporation (NMTC)

Penny Stock Hub, The Stock Market Watch, YCharts, OTC Markets, Street Insider, Trading View, Wallmine, Marketbeat, Business Insider, InvestorsHub, 4-Traders and Stockopedia reported on NeuroOne Medical Technologies Corporation (NMTC), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

NeuroOne Medical Technologies Corporation concentrates on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is changing the landscape of surgical care for neurological disorders via the development of high-definition, minimally invasive diagnostics and treatments. NeuroOne Medical Technologies is based in Eden Prairie, Minnesota. The Company lists on the OTC Markets’ OTCQB.

NeuroOne Medical Technologies centers on the development and commercialization of thin film electrode technology for cEEG and sEEG recording, brain stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson’s Disease, Dystonia, Essential Tremors and other related brain related disorders. It believes that technology in its pipeline can improve outcomes through lessening the risk of infection; decreasing inflammation of the brain during recording; and increasing accuracy and specificity of recorded brain activity.

In addition, the Company believes that technology in its pipeline can improve outcomes through minimizing invasiveness of the procedure; and reducing time-consuming, cumbersome, and expensive technical use and management within facilities. NeuroOne’s focus is on the development and commercialization of Diagnostic Recording and Therapeutic Modalities.

In 2017, NeuroOne Medical Technologies filed two provisional patents with the U.S. Patent and Trade Office (USPTO). Furthermore, the Company completed early feasibility testing for depth electrode and combination diagnostic/ablation depth electrode.

It also established its Physician Advisory Board and raised more than $1.8 million in private transactions. The Company also completed a reverse merger and up-listed to the OTCQB.

The main current goals for NeuroOne Medical Technologies are to file patent application(s) based on the submitted 2017 provisional patents, and complete pre-clinical study for its diagnostic and diagnostic/ablation combination depth electrode. Moreover, main goals include submitting a 510(k) application for cortical electrode this year, ramping up production and hiring initial sales force representatives for cortical electrode. Moreover, primary goals include continuing to strengthen its Physician Advisory Board where appropriate.

NeuroOne Medical Technologies Corporation (NMTC), closed Friday's trading session at $5.00, even for the day, on 2,347 volume. The average volume for the last 60 days is 6,591 and the stock's 52-week low/high is $2.50/$10.00.


Ethos Gold Corp. (ETHOF)

MarketWatch, InvestorsHub, YCharts, 4-Traders, The Street, Stockhouse, Streetwise Reports, and TradingView reported on Ethos Gold Corp. (ETHOF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Ethos Gold Corp. centers on the acquisition and exploration of mineral properties around the world. Currently, it holds one property in the White Gold District in the Yukon Territory. Ethos Gold has 100 percent ownership in the WC property. The Company primarily explores for gold, antimony, arsenic, lead, and silver deposits.

Ethos Gold is based in Vancouver, British Columbia. Incorporated in 2007, the Company formerly went by the name Ethos Capital Corp. It changed its name to Ethos Gold Corp. in April 2012. The Company lists on the OTC Markets Group’s OTCQB.

Ethos Gold’s WC property comprises 44 contiguous quartz claims totaling about 815 ha. The WC property is a target for intrusion-related 'Pogo-style' mineralization or fault controlled epithermal systems such as the close by Coffee Deposit.

Ethos Gold contracted Ground Truth Exploration, Inc. in 2012 to conduct a small 301 soil geochemical sampling program for the WC property. This was completed in July 2012.

The intention of this program was to identify areas of interest based on anomalous gold in soil values and to establish the mineral potential of the property. Samples were collected along 10 sample lines. Individual samples were collected with 50 meters between stations along traverse lines.

Fourteen sample sites returned values in excess of 10 ppb Au with a maximum value of 171 ppb Au. The sample with the second highest gold concentration (119 ppb Au) has coincident anomalous antimony (19 ppm Sb), arsenic (117 ppm As), lead (200 ppm Pb), and silver (13 ppm Ag).

The anomalous multi-element chemistry is akin to that identified by the Company at the Betty property, attributed to bonanza vein mineralization derived from and related to Western Copper's Casino Au-Cu-Mo porphyry.

Last month, Ethos Gold’s Board of Directors announced, with great sadness, the sudden death of its Founder, President and Chief Executive Officer (CEO), Mr. Gary Freeman. Mr. Freeman was a prolific venture capital financier and company builder. He contributed to the success of numerous Canadian listed issuers.

Mr. Freeman was formerly the President and CEO of Pediment Gold Corp. from 2005 to 2011. Mr. Freeman was instrumental in financing, marketing, as well as shareholder relations' capacities with several junior exploration companies.

Mr. Craig Roberts was appointed by the Board of Directors to serve as President and CEO on an interim basis to oversee daily operations and corporate strategy. Mr. Roberts will act in this capacity until the Board of Directors identifies a suitable candidate for the position of President and CEO.

Ethos Gold Corp. (ETHOF), closed Friday's trading session at $0.0936, up 0.65%, on 12,000 volume. The average volume for the last 60 days is 12,000 and the stock's 52-week low/high is $0.09/$0.23.


Artelo Biosciences, Inc. (ARTL)

Stockwatch, OTC Markets, Stockopedia, The Street, Dividend Investor, TradingView, Stockhouse, Wallmine, Simply Wall St, Market Screener, Real Investment Advice, Market Exclusive and Venture Line reported on Artelo Biosciences, Inc. (ARTL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Artelo Biosciences, Inc. is a biopharmaceutical company focused on the development of therapeutic treatments, which modulate the endocannabinoid system. The Company is advancing a portfolio of widely applicable product candidates. The design of these is to address significant unmet needs in numerous diseases and conditions, including cancer, pain, and inflammation. Artelo Biosciences is headquartered in La Jolla, California.

The endocannabinoid system (ECS) is a widespread neuromodulatory system. It plays a crucial role in human central nervous system development, synaptic plasticity, and the response to endogenous and environmental insults. Artelo Biosciences’ approach exploits manifold mechanisms to modulate the ECS. Candidate therapeutic compounds in the Company’s present portfolio are founded on targeting cannabinoid receptors and endocannabinoid transport inhibition utilizing synthetic cannabinoids and new chemical entity approaches.

The Company’s focus is on providing patient access to new therapies and applying proven biopharma thoroughness to its development programs. In addition, the Company is driving unique endocannabinoid system modulating therapeutics into new areas. Furthermore, it is partnering with world-class experts.

In April 2018, Artelo Biosciences and The Research Foundation For The State University of New York (RF/SUNY) announced that they entered into a license agreement.  With this agreement, Artelo obtains an exclusive global license to an intellectual property (IP) portfolio of Fatty Acid Binding Protein (FABP) inhibitor drug candidates that have multiple potential indications, including cancer, inflammation and pain.

During the first year of the agreement, Artelo Biosciences will collaborate with the Stony Brook University team that developed the technology to identify a lead development compound, develop a pharmaceutically acceptable formulation, and evaluate activity in nonclinical animal models across select indications. RF/SUNY is a not-for-profit organization and the largest comprehensive university-connected research foundation in America.

Recently, Artelo Biosciences announced that it entered into a worldwide research and development partnership with Syngene International Ltd., an India-based integrated discovery-development service provider, via its wholly-owned subsidiary, Trinity Research and Development Limited, and Aptus Clinical Ltd., a specialist UK-based Clinical Contract Research Organization (CRO) with specific expertise in oncology, rare diseases and advanced therapies. This partnership will concentrate on supporting the drug discovery and clinical development of ART27.13, Artelo Biosciences’ Phase 2 ready, high-potency dual cannabinoid agonist, in oncology.

Artelo Biosciences, Inc. (ARTL), closed Friday's trading session at $1.30, even for the day, on 1,900 volume. The average volume for the last 60 days is 119 and the stock's 52-week low/high is $0.50/$2.70.


OncBioMune Pharmaceuticals, Inc. (OBMP)

MissionIR, Otcstockexchange, Whisper from Wall Street, and Journal Transcript reported on OncBioMune Pharmaceuticals, Inc. (OBMP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OncBioMune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the development of targeted cancer therapies, a proprietary cancer vaccine technology, and commercialization of a portfolio of products globally. OncBioMune has a proprietary Vaccine Technology designed to stimulate the immune system to attack its own cancer while not hurting the patient. The Company incorporates scientifically proven and clinically validated treatments for cancer. OncBioMune Pharmaceuticals is based in Baton Rouge, Louisiana. The Company lists on the OTCQB.

OncBioMune Pharmaceuticals’ lead product is ProscaVax™. This is its novel cancer vaccine for prostate cancer. ProscaVax is now undergoing evaluation in a Phase 1 clinical study at the University of California San Diego Moores Cancer Center and Veterans Hospital in La Jolla, California, funded in part by the Department of Defense US Navy Cancer Vaccine Program.

ProscaVax consists of a combination of prostate cancer associated PSA with the biological adjuvants interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF). 

Moreover, the Company has a portfolio of targeted therapies. Some of these are biosimilars to blockbuster drugs. OncBioMune has developed the therapeutic cancer vaccine for prostate cancer patients using similar techniques developed for breast cancer patients.

OncBioMune states that it is tested and laboratory proven and that it could become the standard of care for prostate cancer treatment. OncBioMune Pharmaceuticals uses patented technology developed and or acquired by the Company.

In September 2017, OncBioMune Pharmaceuticals announced that it successfully attained development milestones in formulation and stability with tretinoin, also known as all-trans retinoic acid (ATRA). This is an oral drug for the treatment of Acute Promyelocytic Leukemia (APL).  The Company owns the commercialization rights for tretinoin throughout Mexico, Central America, and Latin America.

Earlier this month, OncBioMune Pharmaceuticals provided the latest data from its successfully completed Phase 1 trial of ProscaVax for prostate cancer, suggesting a durable response 31 weeks post-therapy. In the Phase 1 clinical trial, hormone-naïve and hormone-independent recurrent prostate cancer patients with rising prostate specific antigen (PSA) were treated with six intradermal injections of ProscaVax.

Dr. Jonathan Head, Chief Executive Officer at OncBioMune Pharmaceuticals, said, “I’m very excited about this data, as I can’t think of another study to have 75 percent of recurrent prostate cancer patients with rising PSA experience stable disease nearly eight months after therapy ended. .. Now, we have to expand the therapeutic range and increase the number of patients enrolled in mid-stage research, but the data to date certainly is encouraging to provide a safe and effective treatments for the millions of men battling prostate cancer today.”

OncBioMune Pharmaceuticals, Inc. (OBMP), closed Friday's trading session at $0.0214, off by 2.73%, on 302,544 volume. The average volume for the last 60 days is 629,643 and the stock's 52-week low/high is $0.01/$0.17.


The QualityStocks Company Corner

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is fired up in the search for lithium to power the new age, and a new electrolyte may make battery fires a thing of the past. To view the full article, visit:

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.275, up 1.78%, on 99,920 volume. The average volume for the last 60 days is 98,636 and the stock's 52-week low/high is $0.078/$1.46.

Recent News


VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Canna Farms Limited (“Canna Farms”), has completed an agreement with the Ontario Cannabis Store (the “OCS”) to supply the Province of Ontario with high-quality cannabis products.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $1.3776, up 5.97%, on 596,149 volume. The average volume for the last 60 days is 857,087 and the stock's 52-week low/high is $1.04/$1.50.

Recent News


Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

As lucrative as the budding cannabis market promises to be, the business of providing goods and services to cannabis companies is likely to be much larger, which is why Cannabis Strategic Ventures, Inc. (OTC: NUGS) has adopted its present strategic position (

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $4.13, up 2.49%, on 68,927 volume. The average volume for the last 60 days is 90,834 and the stock's 52-week low/high is $0.03/$7.13.

Recent News


Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces strategic additions to its patent portfolio. Three new Australian patents were granted to Lexaria by the Australian Patent Office, bringing the Company's worldwide patent portfolio to eight issued patents: four each in the US and Australia. Also today, LXRP was showcased in the Venture Breakfast Bits by 24/7 Market News. Follow the link to get the full press release (

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $2.03, up 2.01%, on 138,486 volume. The average volume for the last 60 days is 232,021 and the stock's 52-week low/high is $0.32/$2.54.

Recent News


Sharing Services, Inc. (SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services, Inc. (OTC: SHRV) reported its third consecutive record gross sales month, reaching more than $4 million in May. This followed highs of $3.5 million in April and $2.4 million in March ( SHRV said that its record sales are being driven by the success of its Elevacity products. May SHRV sales clocked in at the company’s best monthly total since the launch of Elevacity last December, the company said.

Sharing Services, Inc. (SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.32, even for the day. The average volume for the last 60 days is 17,838 and the stock's 52-week low/high is $0.125/$0.92.

Recent News


DeepMarkit Inc. (TSX-V: MKT) (OTC: MKTDF)

The QualityStocks Daily Newsletter would like to spotlight DeepMarkit Inc. (MKTDF).

DeepMarkit (TSX-V: MKT) (OTCQB: MKTDF) is cleverly leveraging gamification to promote products, generate leads, and drive customer engagement and loyalty. To view the full article, visit:

DeepMarkit Inc. (TSX-V: MKT) (OTC: MKTDF), based in Calgary, Alberta, Canada, is a patent pending gamification technology company inventing new ways to engage consumers and other audiences. The Company’s proprietary promotions platform – “Gamify” – enables businesses and agencies to create branded games that incentivize consumers, thus driving sales, capturing data and generating leads. The DeepMarkit platform integrates next-gen gamification engagement mechanics with interactive advertising industry standards and powerful visuals, including 3-D images. Customers may choose from both free and paid solutions suitable for campaigns of all sizes, targeting multiple channels on the web, mobile and social media.

A team of seasoned, passionate gaming executives, led by president and CEO Darold Parken, has worked together for more than 15 years developing games and gaming systems that are still used today by some of the largest gaming companies in the world. This accomplished executive team founded Chartwell Technologies, acquired in 2011 by Amaya Gaming, which now is known as The Stars Group (Nasdaq: TSG) with a market cap of over $5 billion.

Gamify offers a selection of easily customizable gaming apps featuring a customer’s branded e-store in addition to tailored landing pages, technical support, real-time analytics, data collection and an engaging marketing campaign. Gamify’s patent-pending app comes complete with unique user incentives that draw consumers in with games and prizes, which in turn engages shoppers, turning them into buyers and building brand loyalty.

The gamification market is rapidly expanding and projected to be worth $22 billion by 2022, with a CAGR of 41 percent. DeepMarkit is the only publicly listed company focused solely on this exploding market that embraces any size of business, from the mom-and-pop shops to the blue-chip giants. DeepMarkit’s management team knows that increasing a customer’s conversion rate by a mere 1 percent has the potential to double revenue, which is why Gamify’s app and its ability to transform simple shoppers into engaged buyers is so compelling.

“Our marketing platform enables customers to build branded games that incentivize audiences, generate leads, and drive sales. Businesses need a way to stand out from the crowd,” Parken states in an investor’s video ( “DeepMarkit’s gamification platform gives customers that way to stand out and it’s a way that they can afford. That’s the strength of our platform. For a relatively small amount of money, any business can create a very powerful, high quality customer engagement using gamification.”

DeepMarkit recently entered into a joint marketing agreement with ITN International (“ITN”), a global leader in trade show data capture and analytics. The agreement will enable the 1.5 million exhibitors at the 125-plus yearly events serviced by ITN to purchase a customizable campaign with prize delivery and branded games that can be used in collaboration with ITN’s lead retrieval solutions. DeepMarkit and ITN are currently integrating DeepMarkit’s patent-pending gamification platform directly into ITN’s exhibitor portal.

“We started DeepMarkit because we have a passion for games and we believe in the power of games, not just for entertainment but more importantly as a tool for business,” Parken said. “DeepMarkit is a gamification company. What we mean by that is that we create innovative ways to use games for business purposes. Games to generate customer leads, games to promote products, deliver rewards, build brand awareness and customer loyalty.”

Selected as the winner of the New Company/Product pitch competition at the Retail Global 2017 Conference held in Las Vegas, Gamify’s platform has also attracted a $1.5 million investment from Allstate International LLC in Hong Kong. The investment gives Allstate a 10 percent stake in DeepMarkit and a great opportunity to bring the Gamify platform into the burgeoning Asian gaming market.

DeepMarkit Inc. (MKTDF), closed the day's trading session at $0.0203, even for the day. The average volume for the last 60 days is 24,629 and the stock's 52-week low/high is $0.0195/$0.1199.

Recent News


Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH).

Based in Atlanta, Georgia, Consorteum Holdings, Inc. (OTC: CSRH) is a software development and mobile publishing company. Its Universal Mobile Interface™ (UMI) technology enables the company to jointly develop internal and third-party solutions for a wide array of vertical markets. Consorteum’s 359 Mobile, Inc. subsidiary sees promise for its UMI platform as smartphone use continues to expand globally.

Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company’s commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ (“UMI”) solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company’s UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum’s wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company’s UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI’s technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum’s primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum’s management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum’s management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors.

Consorteum Holdings, Inc. (CSRH), closed the day's trading session at $0.0013, even for the day. The average volume for the last 60 days is 2,490,772 and the stock's 52-week low/high is $0.0006/$0.0085.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. To view the full interview, visit: To view the full press release, visit:

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0312, up 0.65%, on 3,326,569 volume. The average volume for the last 60 days is 4,098,290 and the stock's 52-week low/high is $0.024/$0.88.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX).

In a recent press release (,, Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, reported a 41 percent year-over-year increase in revenues for the 2018 fiscal year. The company attributes the majority of this increase to consumer product sales through its wholly owned subsidiaries, Inc. and CBD Biotechnology Co., Ltd.

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.49625, off by 2.70%, on 125,675 volume. The average volume for the last 60 days is 240,067 and the stock's 52-week low/high is $0.37/$1.58.

Recent News


Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Targeting the high-end medical and adult-use recreational market, Green Hygienics Holdings (OTC: GRYN) is a full-scope, premium cannabis cultivation company. To view the full article, visit:

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.40, off by 2.44%, on 92,120 volume. The average volume for the last 60 days is 69,432 and the stock's 52-week low/high is $0.01/$0.50.

Recent News



The QualityStocks Daily Newsletter would like to spotlight GTX Corp (GTXO).

GTX Corp (OTC: GTXO), a pioneer in the field of wearable GPS tracking and wandering assistive Internet of Things (IoT) technology, is quickly becoming a go-to provider of innovative solutions that monitor, track and relay the locations of both assets and people. In a news release, GTX announced that it has received a new contract from Edwards Air Force Base (AFB) for additional units of the company’s Personnel, Equipment Tracking System (P.E.T.S.), a lightweight, mobile non-cellular, encrypted GPS technology platform designed to track personnel and equipment (

GTX Corp (GTXO), a For Profit For Purpose company, designs, manufactures and commercializes various products and services in the GPS tracking and monitoring business. Operating domestically and internationally, via two subsidiaries engaged in the internet of things (IoT) and wearable technology industry. Founded in 2002 and headquartered in Los Angeles, California, the company is a pioneer in Smart GPS, cellular and Bluetooth Low Energy (BLE) tracking technology, offering complete, end-to-end tracking solutions through a proprietary IoT enterprise monitoring platform – the IoT Machine to Machine platform – backed by state-of-the-art hardware, software and connectivity solutions, patents and software algorithms.

Operating under the motto “We Put the ‘Where’ in Wearable Tech,” GTX’s main goal is to keep its customers connected to who and what matters most, with each of its patented tracking technologies providing real-time location coordinates on a map via a personalized portal. The company prides itself on offering not only technologies, but also effective solutions that provide safety, security and peace of mind by helping customers locate their loved ones or lost valuable items.

With a portfolio that includes more than 80 patents filed and issued and with products and services available in 35 countries, GTX’s tracking solutions use the latest in miniaturized, low-power GPS, mobile, RF and BLE technology, that can integrate seamlessly with multiple consumer products, enterprise and military applications. The company became a U.S. Military contractor in 2017 and is already developing asset and human tracking technology for the U.S. Air Force. Its list of customers also includes public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers.

The company’s flagship product is the award-winning GPS SmartSole®, the world’s first invisible wearable tracking device created specifically for people at risk of wandering, becoming lost or disoriented, including patients with Alzheimer’s, autism, dementia, traumatic brain injury and other cognitive problems. According to the World Alzheimer Report 2013 (, there are more than 100 million people worldwide who need constant care and monitoring because of a cognitive disorder, and their number is expected to rise to 277 million by 2050. Due to its hidden location – inside a shoe insert, the device can also be used by people undercover or at risk of kidnapping, such as government agents, military personnel, law enforcement, journalists, corporate executives, etc.

Other tracking devices designed and commercialized by the company for civilian or military use include:

  • Take-Along Tracker 3G: A powerful mini-tracking device with GPS, 2G and 3G GSM data and voice capabilities, as well as a motion sensor and sleep mode. The device can be easily attached to a keychain, lanyard, dog collar, pocket, bag or plush toy for a discreet but advanced tracking solution.
  • Invisabelt: Designed for children, this slim GPS tracker hidden inside a small waistband belt has a battery life of up to two days and is a great solution for parents who want to monitor their children’s location at all times.
  • Track My Workforce: An easy and cost-effective solution that allows businesses to track and monitor their mobile workforce. The app is available for both Android and iOS systems, and allows employers to monitor their workforce from a single company account.
  • P.E.T.S. -Personnel Equipment Tracking System: Currently in use at the Edwards Air Force Base, this tracking system allows real-time monitoring and surveillance of personnel and assets and has a 200+ square mile coverage. Solar powering capabilities and extend battery life allow the tracker to be used in areas without existing power sources.
  • GPS Rifle Tracker: The company’s smallest GPS tracker, designed to withstand shocks and water submersion due to its robust, military standard enclosure, can be mounted on any AR15 platform picatinny rail to detect weapon discharge, track weapons and inventory, and send time and location alerts.

Led by a management team with solid experience in wearable technology, IoT, consumer electronics, mobile and technology licensing, as well as finance and the footwear industry, GTX plans to leverage its core technology platform to reach new verticals via licensing agreements and strategic partnerships, and to monetize its intellectual property portfolio. The monetization campaign kicked off in 2017 has already identified 100 companies that could become licensees. Besides military and law enforcement, the company also eyes the biometrics market, home health, medicare and insurance and other security applications for potential uses of its IoT platform and tracking technology.

GTX currently has 15 domestic and international distributors, subscribers in 35 countries and more than 700 online affiliates. With multiple revenue streams, several consecutive years of double-digit revenue growth and a strong pipeline of lucrative commercial products, GTX is uniquely positioned to become a leading provider of tracking solutions on this growing multi-billion-dollar market.

GTX Corp (GTXO), closed the day's trading session at $0.038, off by 15.74%, on 334,509 volume. The average volume for the last 60 days is 4,932,879 and the stock's 52-week low/high is $0.001/$0.10.

Recent News


Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $4.00, up 9.29%, on 6,317 volume. The average volume for the last 60 days is 1,693 and the stock's 52-week low/high is $2.70/$5.00.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.